Inhibition of lysozyme by taurine dibromamine

Protein and Peptide Letters

Volumn 20, Issue 11, 2013, Pages 1232-1237

  Petronio M S ^a   Ximenes, V F ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Eosinophils; Hypobromous acid; Hypochlorous acid; Lysozyme; Neutrophils; Taurine dibromamine

Indexed keywords

HALOAMINE; LYSOZYME; TAURINE DIBROMAMINE; UNCLASSIFIED DRUG;

AMINO ACID METABOLISM; ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME METABOLISM; FLUORESCENCE ANALYSIS; LIGHT SCATTERING;

ANIMALS; BROMATES; CELL PROLIFERATION; CHICK EMBRYO; CIRCULAR DICHROISM; EGGS; EOSINOPHILS; MICROCOCCUS; MURAMIDASE; NEUTROPHILS; OXIDATION-REDUCTION; TAURINE; TRYPTOPHAN;

EID: 84887939857     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/0929866511320110007     Document Type: Article

References (38)

1. Winterbourn, C.C.; Kettle, A.J. Redox reactions and microbial killing in the neutrophil phagosome. Antioxid. Redox Signal., 2013, 18(6), 642-660.
2. Prokopowicz, Z.; Marcinkiewicz, J.; Katz, D.R.; Chain, B.M. Neutrophil myeloperoxidase: soldier and statesman. Arch. Immunol. Ther. Exp. (Warsz), 2012, 60(1), 43-54.
3. Panasenko, O.M.; Sergienko, V.I. Halogenizing stress and its biomarkers. Vestn. Ross. Akad. Med. Nauk., 2010, 1, 27-39.
4. Dale, D.C.; Boxer, L.; Liles, W.C. The phagocytes: neutrophils and monocytes. Blood, 2008, 112(4), 935-945.
5. Babior, B.M. The leukocyte NADPH oxidase. Isr. Med. Assoc. J. 2002, 4(11), 1023-1024.
6. Schuller-Levis, G.B.; Park, E. Taurine and its chloramine: modulators of immunity. Neurochem. Res., 2004, 29(1), 117-126.
7. Marcinkiewicz, J.; Kontny, E. Taurine and inflammatory diseases. Amino Acids, 2012. doi: 10.1007/s00726-012-1361-4.
8. Kim, C.; Cha, Y.N. Production of reactive oxygen and nitrogen species in phagocytes is regulated by taurine chloramine. Adv. Exp. Med. Biol., 2009, 643, 463-472.
9. Gottardi, W.; Nagl, M. N-chlorotaurine, a natural antiseptic with outstanding tolerability. J. Antimicrob. Chemother., 2010, 65(3), 399-409.
10. Thomas, E.L.; Bozeman, P.M.; Jefferson, M.M.; King, C.C. Oxidation of bromide by the human leukocyte enzymes myeloperoxidase eosinophil peroxidase. Formation of bromamines. J. Biol. Chem., 1995, 270(7), 2906-2913.
11. Marcinkiewicz, J. Taurine bromamine (TauBr)-its role in immunity and new p erspectives for clinical use. J. Biomed. Sci., 2010, 17, Suppl. 1:S3.
12. Ximenes, V.F.; da Fonseca, L.M.; de Almeida, A.C. Taurine bromamine: a potent oxidant of tryptophan residues in albumin. Arch. Biochem. Biophys., 2011, 507(2), 315-322.
13. Nakatsuji, T.; Gallo, R.L. Antimicrobial peptides: old molecules with new ideas. J. Invest. Dermatol., 2012, 132(3), 887-895.
14. Swaminathan, R.; Ravi, V. K.; Kumar, S.; Kumar, M.V.; Chandra, N. Lysozyme: a model protein for amyloid research. Adv. Protein Chem. Struct. Biol., 2011, 84, 63-111.
15. Wine, J.J.; Joo, N.S.; Choi, J.Y.; Cho, H.J.; Krouse, M.E.; Wu, J.V.; Khansaheb, M.; Irokawa, T.; Ianowski, J.; Hanrahan, J.W.; Cuthbert, A.W.; Tran, K.V. Measurement of fluid secretion from intact airway submucosal glands. Methods Mol. Biol., 2011, 742, 93-112.
16. Bhatt, N Y.; Allen, J.N. Update on eosinophilic lung diseases. Semin. Respir. Crit. Care Med., 2012, 33(5), 555-571.
17. Tubby, C.; Harrison, T.; Todd, I.; Fairclough, L. Immunological basis of reversible and fixed airways disease. Clin. Sci. (Lond), 2011, 121(7), 285-296.
18. Petrônio, M.S.; Ximenes, V.F. Effects of oxidation of lysozyme by hypohalous acids and haloamines on enzymatic activity and aggregation. Biochim. Biophys. Acta., 2012, 1824(10), 1090-1096.
19. Kettle, A.J. Detection of 3-chlorotyrosine in proteins exposed to neutrophil oxidants. Methods Enzymol. 1999, 300, 111-120.
20. Tokunaga, S.; Kanayama, A.; Miyamoto, Y. Modification of IkappaBalpha by taurine bromamine inhibits tumor necrosis factor alpha-induced NF-kappaB activation. Inflamm. Res., 2007, 56(11), 479-486.
21. Pace, C.N.; Vajdos, F.; Fee, L.; Grimsley, G.; Gray, T. How to measure and predict the molar absorption coefficient of a protein. Protein Sci., 1995, 4(11), 2411-2423.
22. Peskin, A.V.; Winterbourn, C.C. Taurine chloramine is more selective than hypochlorous acid at targeting critical cysteines and inactivating creatine kinase and glyceraldehyde-3-phosphate dehydrogenase. Free Radic. Biol. Med., 2006, 40(1), 45-53.
23. Thomas, E.L.; Grisham, M.B.; Jefferson, M.M. Preparation and characterization of chloramines. Methods Enzymol., 1986, 132, 569-585.
24. Burstein, E.A.; Vedenkina, N.S.; Ivkova, M.N. Fluorescence and the location of tryptophan residues in protein molecules. Photochem. Photobiol., 1973, 18(4), 263-279.
25. Lu, W.; Shang, J. A resonance light-scattering (RLS) serving for various quantitative events since 1995: a comment proposed towards how to apprehend well the meaning of RLS and its corresponding guiding role. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2009, 74(1), 285-291.
26. Petrônio, M.S.; Zeraik, M.L.; da Fonseca, L.M.; Ximenes, V.F. Apocynin: chemical and biophysical properties of a NADPH oxidase inhibitor. Molecules, 2013, 18(3), 1-19.
27. Shugar, D. The measurement of lysozyme activity and the ultraviolet inactivation of lysozyme. Biochim. Biophys. Acta, 1952, 8(3), 302-309.
28. Pilz, M.; Holinka, J.; Vavken, P.; Marian, B.; Krepler, P. Taurine chloramine induces apoptosis in human osteosarcoma cell lines. J. Orthop. Res., 2012, 30(12), 2046-2051.
29. Kontny, E.; Chorazy-Massalska, M.; Rudnicka, W.; Marcinkiewicz, J.; Maśliński, W. Comparison of taurine chloramine and taurine bromamine effects on rheumatoid arthritis synoviocytes. Amino Acids, 2007, 32(3), 447-452.
30. Petrônio, M.S.; Ximenes, V.F. Light emission from tryptophan oxidation by hypobromous acid. Luminescence, 2012. doi: 10.1002/bio.2445.
31. Teichberg, V.I.; Kay, C.M.; Sharon, N. Separation of contributions of tryptophans and tyrosines to the ultraviolet circular dichroism spectrum of hen egg-white lysozyme. Eur. J. Biochem., 1970, 16(1), 55-59.
32. Knubovets, T.; Osterhout, J.J.; Klibanov, A.M. Structure of lysozyme dissolved in neat organic solvents as assessed by NMR and CD spectroscopies. Biotechnol. Bioeng., 1999, 63(2), 242-248.
33. Tanaka, F.; Forster, L.S.; Pal, P.K.; Rupley, J.A. The circular dichroism of lysozyme. J. Biol. Chem., 1975, 250(17), 6977-6982.
34. Boccù, E.; Veronese, F.M.; Fontana, A.; Fenassi, C.A. Studies on the function of tryptophan-108 on lysozyme. Acta Vitaminol. Enzymol., 1975, 29(1-6), 266-269.
35. Ding, F.; Li, X.N.; Diao, J.X.; Sun, Y.; Zhang, L.; Ma, L.; Yang, X.L.; Zhang, L.; Sun, Y. Potential toxicity and affinity of triphenylmethane dye malachite green to lysozyme. Ecotoxicol. Environ. Saf., 2012, 78, 41-49.
36. Kuroda, M.; Sakiyama, F.; Narita, K. Oxidation of tryptophan in lysozyme by ozone in aqueous solution. J. Biochem., 1975, 78(4), 641-651.
37. Vanderkelen, L.; Van Herreweghe, J.M.; Vanoirbeek, K.G.; Baggerman, G.; Myrnes, B.; Declerck, P.J.; Nilsen, I.W.; Michiels, C.W.; Callewaert, L. Identification of a bacterial inhibitor against g-type lysozyme. Cell. Mol. Life Sci., 2011, 68, 1053-1064.
38. Parameswaran, G.I.; Sethi, S.; Murphy, T.F. Effects of bacterial infection on airway antimicrobial peptides and proteins in COPD. Chest, 2011, 140, 611-617.